Physician profile
Switu Patel
NPI 1902649031
$2,313.22
in general payments reported to CMS, 2019-2025
22 companies · $1,551 in 2025
The $1,551 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $763 · 2025: $1,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,224 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,224.22 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $552.16 | 2024-2025 | Krystexxa, Tavneos, Otezla |
| Novartis Pharmaceuticals Corporation | $283.31 | 2024-2025 | |
| Janssen Biotech, INC. | $258.56 | 2024-2025 | Tremfya |
| Abbvie INC. | $161.45 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $159.12 | 2024-2025 | Orencia |
| Pfizer INC. | $137.92 | 2024-2025 | |
| Ucb, INC. | $129.83 | 2024-2025 | Bimzelx |
| Organon LLC | $100.80 | 2024-2025 | Hadlima, Renflexis |
| Lilly USA, LLC | $68.16 | 2024 | Taltz |
| Radius Health, INC. | $67.43 | 2025 | Tymlos |
| Aurinia Pharma U.S., INC. | $61.61 | 2024-2025 | Lupkynis |
| Ani Pharmaceuticals, INC. | $49.27 | 2024-2025 | Purified Cortrophin Gel |
| Sandoz INC. | $45.40 | 2024 | Hyrimoz |
| Alexion Pharmaceuticals, INC. | $41.99 | 2025 | Strensiq |
| Fresenius Kabi USA, LLC | $40.81 | 2024 | Idacio |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $28.19 | 2024 | Quzyttir |
| Invivyd INC | $25.81 | 2025 | Pemgarda |
| Astrazeneca Pharmaceuticals LP | $24.50 | 2025 | Saphnelo |
| Bioventus LLC | $21.13 | 2025 | Xcell |
| Mallinckrodt Hospital Products INC. | $19.97 | 2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.00 | 2025 | Ofev |
| Tonix Medicines, INC. | $17.80 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Switu Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.